Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease

Heart

Volumn 89, Issue 11, 2003, Pages 1291-1297

  Sabharwal, N K ^a   Lahiri, A ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; TETROFOSMIN TC 99M; THALLIUM 201; TROPONIN;

ANGIOCARDIOGRAPHY; CLINICAL PRACTICE; COMPUTER PROGRAM; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EXERCISE; EXERCISE ELECTROCARDIOGRAPHY; FOLLOW UP; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REVIEW; SCINTILLATION CAMERA; ST SEGMENT DEPRESSION; TECHNIQUE; TREADMILL;

EID: 0142178029     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.11.1291     Document Type: Review

References (57)

1. Pryor DB, Harrell FEJ, Lee KL, et al. Estimating the likelihood of significant coronary artery disease. Am J Med 1983;75:771-80.
2. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
3. Detrano R, Gianrossi R, Froelicher V. The diagnostic accuracy of the exercise electrocardiogram: a meta-analysis of 22 years of research. Prog Cardiovasc Dis 1989;32:173-206.
4. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100:2140-5.
5. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001;37:754-60.
6. Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the duke treadmill score. Circulation 2001;103:2566-71.
7. Stratmann HG, Tamesis BR, Younis LT, et al. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
8. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
9. Pennell DJ, Mavrogeni SI, Forbat SM, et al. Adenosine combined with dynamic exercise for myocardial perfusion imaging. J Am Coll Cardiol 1995;25:1300-9.
10. Khattar RS, Senior R, Joseph D, et al. Comparison of arbutamine stress 99mTc-labeled sestamibi single-photon emission computed tomographic imaging and echocardiography for detection of the extent and severity of coronary artery disease and inducible ischemia. J Nucl Cardiol 1997;4:211-16.
11. Glover DK, Ruiz M, Yang JY, et al. Pharmacological stress thallium scintigraphy with 2-cyclohexylmethylidenehydrazinoadenosine (WRC-0470). A novel, short-acting adenosine A2A receptor agonist. Circulation 1996;94:1726-32.
12. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991;83:363-81.
13. Warn JM, Hakki AH, Iskandrian AS. Prognostic implications of normal exercise thallium 201 images. Arch Intern Med 1985;145:253-6.
14. Vanzetto G, Ormezzano O, Fagret D, et al. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 1999;100:1521-7.
15. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
16. Taillefer R, DePuey EG, Udelson JE, et al. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77.
17. Soman P, Parsons A, Lahiri N, et al. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999;6:252-6.
18. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
19. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002;9:240-5.
20. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47.
21. Faber TL, Cooke CD, Folks RD, et al. Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. J Nucl Med 1999;40:650-9.
22. Nichols K, Santana CA, Folks R, et al. Comparison between ECTb and QGS for assessment of left ventricular function from gated myocardial perfusion SPECT. J Nucl Cardiol 2002;9:285-93.
23. Berman D, Hachamovitch R, Lewin H, et al. Risk stratification in coronary artery disease: implications for stabilization and prevention. Am J Cardiol 1997;79:10-16.
24. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction [Published erratum appears in Circulation 1998;98:190]. Circulation 1998;97:535-43.
25. Mark DB, Shaw L, Harrell FFJ, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.
26. Soman P, Taillefer R, DePuey EG, et al. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. J Am Coll Cardiol 2001;37:458-62.
27. Berman DS, Kiat H, Van Train KF, et al. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990;66:72-9E.
28. Sridhara BS, Braat S, Rigo P, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrafosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015-19.
29. Zaret BL, Rigo P, Wackers FJ, et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin international trial study group. Circulation 1995;91:313-19.
30. Smanio PE, Watson DD, Segalla DL, et al. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol 1997;30:1687-92.
31. Swinburn JMA, Stubbs P, Soman P, et al. Rapid assessment of patients with nonST-segment elevation acute chest pain: troponins, inflammatory markers, or perfusion imaging? J Nucl Cardiol 2002;9:491-9.
32. Chouraqui P, Rodrigues EA, Berman DS, et al. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990;66:689-94.
33. Borges-Neto S, Javaid A, Shaw LK, et al. Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. Radiology 2000;215:529-33.
34. Johnson LL, Verdesca SA, Aude WY, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.
35. Otto AC, van Staden J, van Aardt A, et al. Evaluation of exercise-induced stunning using myocardial perfusion imaging. Cardiovasc J Southern Africa 2001;12:259-62.
36. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999;100:1035-42.
37. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
38. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
39. Beller GA. Assessment of myocardial viability. Curr Opin Cardiol 1997;12:459-67.
40. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33:1848-54.
41. Sansoy V, Glover DK, Watson DD, et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 1995;92:994-1004.
42. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/ technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
43. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92-8.
44. Senior R, Kaul S, Raval U, et al. Impact of revascularisation and myocardial viability determined by nitrate enhanced technetium-99m sestamibi and thallium-201 imaging on mortality and functional outcome in ischaemic cardiomyopathy. J Nucl Cardiol 2002;9:454-62.
45. Siebelink HM, Blanksma PK, Crijns HJ, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol 2001;37:81-8.
46. Kitsiou AN, Srinivasan G, Quyyumi AA, et al. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998;98:501-8.
47. Lahiri A. The role of cardiac imaging in optimizing therapy in heart failure [letter; comment]. J Nucl Cardiol 2000;7:81-4.
48. Cleland JG, Pennell DJ, Ray SG, et al. The Carvedilol Hibernation Reversible Ischaemia Trial: Marker of Success (CHRISTMAS) [abstract]. J Am Coll Cardiol 2002;39(suppl 5A):172A.
49. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 1999;33:661-9.
50. Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe - the EMPIRE study. Eur Heart J 1999;20:157-66.
51. Wackers FJ, Russo DJ, Russo D, et al. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cordiol 1985;6:27-30.
52. Steinberg EH, Koss JH, Lee M, et al. Prognostic significance from 10-year follow-up of a qualitatively normal planar exercise thallium test in suspected coronary artery disease. Am J Cardiol 1993;71:1270-3.
53. Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med 1994;35:554-7.
54. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89:615-22.
55. Raiker K, Sinusas AJ, Wackers FJ, et al. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging. J Nucl Cardiol 1994;1:449-56.
56. Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202-8.
57. Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol 2000;7:333-41.